Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Adenocarcinoma × Negative-Pressure Wound Therapy × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 7 Surgical Wound Infection 5 Pilonidal Sinus 3 Wound Infection 2 Sarcoma 2 Thyroid Nodule 1 Thyroid Neoplasms 1 Thyroid Diseases 1 Spinal Cord Injuries 1 Skin Neoplasms 1 Skin Carcinoma 1 Seroma 1 Postoperative Complications 1 Obesity 1 Non-melanoma Skin Cancer 1 Neoplasm Metastasis 1 Infections 1 Graves Disease 1 Goiter 1 Adenocarcinoma 1

Interventions

Oxaliplatin 46 Gemcitabine 45 Fluorouracil 40 Capecitabine 31 pembrolizumab 29 Leucovorin 29 Docetaxel 27 Cisplatin 25 Paclitaxel 23 Irinotecan 18 Carboplatin 18 Bevacizumab 18 130-nm albumin-bound paclitaxel 17 Pemetrexed 15 Albumin-Bound Paclitaxel 15 Radiotherapy 14 Nivolumab 12 Ramucirumab 11 Cyclophosphamide 11 Trastuzumab 8 Erlotinib Hydrochloride 8 Taxes 7 Radiosurgery 7 Drug Therapy 7 cemiplimab 6 zolbetuximab 5 trastuzumab deruxtecan 5 regorafenib 5 durvalumab 5 Sorafenib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07489820 2026-03-24

AAPICO

Centre Hospitalier Departemental Vendee

Phase NA Not yet recruiting

Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡